SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Lumentum Holdings, Inc. engages in the provision of optical and photonic products. It operates through the Cloud and Networking, and Industrial Tech segments. The Cloud and Networking segment refers to a portfolio of optical and photonic components, modules, and subsystems. The Industrial Tech segment includes solid-state lasers, kilowatt-class fiber lasers, ultrafast lasers, diode lasers, and gas lasers. The company was founded in 1979 and is headquartered in San Jose, CA.

Lumentum Holdings Inc

Marvells agreed all-stock acquisition of Lumentum is driving attention, with Lumentums fixed exchange ratio tying its deal value to Marvells share price. Traders are debating the deals value as LITE falls alongside MRVL, questioning whether the headline premium holds up as the acquirers stock weakens.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvells agreement to acquire Lumentum in an all-stock deal is the dominant focus, with traders concerned about shareholder dilution, financing, and integration risks as the stock sells off. Others see strategic value in combining Marvells AI-connectivity business with Lumentums optical technology, but debate how long the benefits may take to materialize.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

Buzz centers on reports that a POET optical engine appeared in Foxconns photonics ecosystem at Hon Hai Tech Day, which bulls view as validation of the FIT collaboration and POETs AI data-center optics opportunity. The display has not confirmed production orders or scaled shipments, leaving traders divided between optimism about commercialization and frustration over the lack of concrete customer updates ahead of earnings.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

A sharp breakout to fresh 52-week highs has drawn attention as traders focus on the upcoming Q3 report and BRIUMVIs commercial momentum. Buyout and short-squeeze theories are also prominent, but remain speculation; some traders attribute the move to earnings positioning and momentum instead.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

Axsomes third-quarter results beat expectations, with strong revenue growth led by Auvelity and a narrower-than-expected loss. Traders welcomed the report and see cash-flow break-even approaching, while the lack of formal guidance drew some concern.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals European Lithium acquisition is driving attention, with traders weighing greater ownership of Tanbreez and added assets against dilution and potential selling pressure from newly issued shares. High reported short interest and borrowing costs have fueled squeeze speculation, though the community is divided over whether the deal is ultimately bullish or a near-term overhang.

Cipher Digital, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business. The company was founded in 2021 and is headquartered in New York, NY.

Cipher Digital Inc.

CIFRs quarterly results are driving discussion, with traders criticizing weak revenue and ongoing cash-generation and financing concerns despite reported progress bringing HPC leases into service. The reaction is split between fears that debt and the miner-to-AI infrastructure transition will weigh on the stock and bullish arguments that contracted leases and continued AI demand support the longer-term case.

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Tempus AI Inc. - Ordinary Shares - Class A

Tempus AI Inc

Tempus AIs Q3 results and higher full-year revenue guidance are driving discussion, with traders noting the reported EPS beat and asking whether the company is finally GAAP-positive. Despite the upbeat report, shares are lower, fueling debate over a sell-the-news reaction versus improving fundamentals.

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the Biopharmaceuticals and Exemplar segments. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Precigen Inc

FDA accelerated approval of Inovios competing RRP treatment has focused attention on potential competition for Precigens PAPZIMEOS and prompted concern about its market position. Traders debate whether the rivals treatment regimen will pressure PAPZIMEOS or whether Precigens commercial head start, payer access, and full-approval status will help it retain an advantage.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

A sharp selloff across AI and optical-infrastructure stocks, alongside concerns about hyperscaler spending and financing, is driving attention to AAOI ahead of earnings. Traders are split between viewing the drop as an oversold opportunity given data-center transceiver demand and worrying about further losses amid volatility and potential dilution.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Avantor, Inc. (AVTR) is a Great Momentum Stock: Should You Buy?

Does Avantor, Inc. (AVTR) have what it takes to be a top stock pick for momentum investors? Let's find out.

Avantor (AVTR) Upgraded to Buy: What Does It Mean for the Stock?

Avantor (AVTR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Is Avantor (AVTR) Stock Outpacing Its Medical Peers This Year?

Here is how Avantor, Inc. (AVTR) and Novartis (NVS) have performed compared to their sector so far this year.

Avantor Q3 2026 Earnings Call Transcript

Avantor (NYSE:AVTR) reported third-quarter financial results on Wednesday. The transcript from the company's third-quarter earnings call has been provided below.This transcript is brought to you by Benzinga APIs. Forread more...

Avantor, Inc. (AVTR) Surpasses Q3 Earnings and Revenue Estimates

Avantor (AVTR) delivered earnings and revenue surprises of +4.76% and +3.53%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

Avantor Reports Third Quarter 2026 Results

Avantor Reports Third Quarter 2026 Results Avantor Reports Third Quarter 2026 ResultsPR NewswireRADNOR, Pa., Oct. 28, 2026 Net sales of $1,698.3 million; increase of 4.6%; organic increase of 5.2%Diluted GAAP EPS of $0.30; adjusted EPS of $0.22Raised FY 2026 organic revenue growth, adjusted EPS and...

Avantor appoints new Chief Information Officer

Avantor appoints new Chief Information Officer Avantor appoints new Chief Information OfficerPR NewswireRADNOR, Pa., Oct. 26, 2026 RADNOR, Pa., Oct. 26, 2026 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life...

Healthcare Stocks Ignite: Oncology Pushes, Breakout Battles, and Next Big Growth Catalysts

Healthcare stocks are heating up, and investors have a fresh lineup of catalysts to watch. Pfizer (NYSE:PFE) is pushing its oncology story back into the spotlight, while NeOnc Technologies Holdings (NASDAQ:NTHI) is emerging as a high-volatility biotech to watch as brain-cancer milestones, Abu Dhabi expansion and a battle around key technical levels converge. Avantor (NYSE:AVTR) faces a crucial earnings test that could determine whether its recovery has more room to run, while Eli Lilly and Co (NYSE:LLY) is building on its blockbuster drug franchise with encouraging new pediatric clinical data. Takeda Pharmaceutical (NYSE:TAK) brings global pipeline potential and diversified drug-market exposure to the mix, while MoonLake Immunotherapeutics (NASDAQ:MLTX) is drawing trader attention with active trading putting its next potential catalyst under the microscope.

Here's Why You Should Add Avantor Stock to Your Portfolio for Now

AVTR's improving commercial execution, specialty product strength and raised 2026 outlook signal recovery potential despite lingering demand challenges.

Is McKesson (MCK) Outperforming Other Medical Stocks This Year?

Here is how McKesson (MCK) and Avantor, Inc. (AVTR) have performed compared to their sector so far this year.

• Reported GAAP EPS of $0.22
• Reported revenue of $1.7B up 4.59% YoY
• Avantor raised FY 2026 organic revenue growth guidance to +0.75% to +1.25%, adjusted EPS guidance to $0.81 to $0.83, and free cash flow guidance to $525M to $550M.

Avantor adjusted EBITDA and margin were below prior-year levels, VWR Distribution & Services adjusted operating income and margin declined amid unfavorable mix and higher SG&A, and free cash flow fell.

Avantor returned to year-over-year sales growth with 5.2% organic growth, VWR organic growth accelerated to 5.8%, Bioscience & Medtech returned to organic growth, and management cited robust free cash flow.

Avantor, Inc. is a life science tools company that engages in providing mission-critical products and services to the life sciences and advanced technology industries. Its portfolio includes biopharma, healthcare, education and government, as well as advanced technologies and applied materials industries. It sells materials, equipment, instrumentation, and offers specialty procurement. The company operates through the Laboratory Solutions segment and Bioscience Production. The Laboratory Solutions segment focuses on research, diagnostic, and quality control workflows. The Bioscience Production segment focuses on high-purity materials for bioprocessing and medical technologies. Avantor was founded by John Townsend Baker in 1904 and is headquartered in Radnor, PA.

Avantor Inc.

SoFi, Warner Bros. Discovery, Avantor, Conagra, Nvidia: What Sparked Heavy After-Hours Trading In These 5 Stocks?

Equity

Bullish Sentiment

Stocks rebounded on Tuesday, with the defensives and small-caps once again coming to the market’s rescue. Rate hopes have been driving sector rotation out of overvalued growth stocks and into underperforming small caps.The following stocks saw significant volume in the after-hours session:SoFi Technologies, Inc. (SOFI)After-hours move: +0.98%Trading volume: 16.95 millionShares of digital financial services company SoFi rallied to an all-time high of $26.60 in Tuesday’s regular session before pulling back and closing down over 2% at $25.62.&nbsp;Last week, JPMorgan and Citi raised their price targets for&nbsp;<a href="https://stocktwits.com/symbol/SOFI">SoFi stock</a>. JPMorgan upped the price target to $24 from $22 and maintained its ‘Neutral’ rating on the stock, while Citi lifted the price target to $28 from $21 and maintained its ‘Buy’ rating.JPMorgan based its optimism on its more positive stance toward fintech lenders, citing potential Fed rate cuts and stable credit trends. Citi said it expects SoFi’s momentum to continue with its crypto offerings that will likely boost margins. The firm also noted stable credit trends.On Stocktwits, sentiment toward SoFi stock remained ‘bullish’ (65/100), although the degree of optimism had tempered from the previous day. The message volume, however, was at ‘normal’ levels.<figure class="image"><img style="aspect-ratio:619/52;" src="https://news.stocktwits-cdn.com/Screenshot_2025_08_26_at_11_51_09_PM_png_dfc21bc02c.webp" alt="Screenshot 2025-08-26 at 11.51.09 PM.png" width="619" height="52"><figcaption>SOFI sentiment and message volume as of 11:45 a.m. ET, Aug. 26 | source: Stockwits&nbsp;</figcaption></figure>SoFi stock has gained over 66% this year.Warner Bros. Discovery, Inc. (WBD)After-hours move: +0.17%Trading volume: 16.42 million<a href="https://stocktwits.com/symbol/WBD">Warner Bros. Discovery stock</a> underperformed the broader market on Tuesday, dropping about 2% in the regular session. The frenzied after-hours activity came despite a lack of any solid catalysts.The media conglomerate is pursuing plans to split into two: Warner Bros., focusing on streaming and studios and Discovery Global, comprising its TV networks, Discovery+ and other assets. The breakup is expected to be completed in mid-2026.The company’s streaming business is in focus, given that its traditional businesses are suffering, and Apple recently raised its Apple TV+ prices in the U.S. and select international markets.On Stocktwits, retail sentiment toward Warner Bros. Discovery stock stayed ‘bearish’ (34/100), with the message volume at ‘low’ levels.<figure class="image"><img style="aspect-ratio:619/56;" src="https://news.stocktwits-cdn.com/Screenshot_2025_08_26_at_11_49_56_PM_png_01627681ba.webp" alt="Screenshot 2025-08-26 at 11.49.56 PM.png" width="619" height="56"><figcaption>WBD sentiment and message volume as of 11:45 a.m. ET, Aug. 26 | source: Stockwits&nbsp;</figcaption></figure>The stock has risen nearly 12% this year.&nbsp;Avantor, Inc. (AVTR)After-hours move: +1.05%Trading volume: 16.25 millionShares of Avantor, which provides products and services to multiple end markets, including&nbsp;biopharma, healthcare, education and applied materials. The Randor, Pennsylvania-based company reported earlier this month a 1% drop in second-quarter revenue and adjusted earnings per share (EPS) of $0.24. Both metrics trailed expectations.There has also been a change of guard at the company, with Emmanuel Ligner, a life sciences industry veteran, taking over as CEO on Aug. 18. Last Friday, the company disclosed that board member Gregory Summe bought shares in the company.Avantor’s stock elicited ‘neutral’ sentiment (50/100) among retailers, and the message volume was ‘low.’<figure class="image"><img style="aspect-ratio:621/50;" src="https://news.stocktwits-cdn.com/Screenshot_2025_08_26_at_11_48_54_PM_png_8399979b20.webp" alt="Screenshot 2025-08-26 at 11.48.54 PM.png" width="621" height="50"><figcaption>AVTR sentiment and message volume as of 11:45 a.m. ET, Aug. 26 | source: Stockwits&nbsp;</figcaption></figure>It has fallen nearly 37% this year.Congra Brands, Inc. (CAG)After-hours move: +0.11%Trading volume: 14.63 millionThe Chicago, Illinois-based consumer packaged foods company may have come on investors’ radar after its stock fell nearly 2% in Tuesday’s session amid the general weakness seen in the consumer staples space.Retail sentiment toward&nbsp;<a href="https://stocktwits.com/symbol/CAG">ConAgra stock</a>, however, remained ‘bullish’ (71/100), and the message volume was at ‘high’ levels.<figure class="image"><img style="aspect-ratio:617/51;" src="https://news.stocktwits-cdn.com/Screenshot_2025_08_26_at_11_47_59_PM_png_7a2f34c244.webp" alt="Screenshot 2025-08-26 at 11.47.59 PM.png" width="617" height="51"><figcaption>CAG sentiment and message volume as of 11:45 a.m. ET, Aug. 26 | source: Stockwits&nbsp;</figcaption></figure>The stock is down over 29% for the year-to-date period.Nvidia Corp. (NVDA)After-hours move: +0.32%Trading volume: 11.19 millionNvidia remains in the spotlight ahead of its earnings report, due on Wednesday. The stock has gained over 35% year-to-date.&nbsp;On Tuesday, Broadcom announced that it is working to integrate Nvidia's artificial intelligence (AI) technology into its VMware Cloud platform. Separately, Firefly Neuroscience (AIFF) unveiled its new CLEAR platform powered by Nvidia’s L40S GPU with Ada Lovelace architecture.Sentiment toward <a href="https://stocktwits.com/symbol/NVDA">Nvidia stock</a> continued to be ‘bullish’ (66/100), with the buoyant mood accompanied by ‘high’ message volume levels.<figure class="image"><img style="aspect-ratio:615/56;" src="https://news.stocktwits-cdn.com/Screenshot_2025_08_26_at_11_44_13_PM_png_00e740043a.webp" alt="Screenshot 2025-08-26 at 11.44.13 PM.png" width="615" height="56"><figcaption>NVDA sentiment and message volume as of 11:45 a.m. ET, Aug. 26 | source: Stockwits&nbsp;</figcaption></figure>For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-n-cino-stock-surged-11-higher-in-today-s-extended-trading/chsxVoeRdkO">Why nCino Stock Surged 11% Higher In Today’s Extended Trading</a>

Traders work on the floor of the New York Stock Exchange (NYSE) on June 18, 2025 in New York City. 

 SoFi’s record run triggered increased activity in the stock, while underperformance proved positive for certain other names.

Conagra Brands Inc

SoFi Technologies Inc

Warner Bros Discovery Inc

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '26	$0.22	--	--	N/A
Q3 '26	$0.21	$0.22	5.15%	BEAT
Q2 '26	$0.19	$0.21	10.39%	BEAT
Q1 '26	$0.16	$0.17	8.30%	BEAT
Q4 '25	$0.22	$0.22	0.45%	BEAT

Feed

News

Sentiment

Earnings

Fundamentals

Info

AVTR Earnings

Latest Earnings Results: Q3 '26

Historical Earnings